What will be the primary focus of Harvard's 2025 Title VI report?
Antisemitism • 25%
Racial Discrimination • 25%
Gender Discrimination • 25%
Other • 25%
Harvard University's annual report on Title VI complaints
Harvard Settles Title VI Antisemitism Lawsuits, Adopts IHRA Definition and Partners with Israeli University
Jan 21, 2025, 08:49 PM
Harvard University has settled two Title VI lawsuits that accused the institution of failing to adequately address antisemitism on campus. The settlements, reached just one day after President Donald Trump's inauguration, include Harvard's adoption of the International Holocaust Remembrance Alliance's (IHRA) definition of antisemitism. This definition will be integrated into the university's anti-discrimination and anti-bullying policies. Harvard will also clarify that these policies protect Jewish and Israeli students, and will establish an official partnership with a university in Israel. Additionally, the university will appoint a dedicated individual to handle antisemitism complaints and will produce annual reports on Title VI complaints for the next five years. The lawsuits were filed by Students Against Antisemitism and the Brandeis Center for Human Rights Under Law, with allegations stemming from incidents following Hamas' attack on Israel in October 2023. Harvard's decision to settle comes amidst a broader context of universities addressing similar complaints ahead of potential changes in federal policy under the new administration.
View original story
No • 50%
Yes • 50%
DEI programming • 25%
Mental health initiatives • 25%
Other • 25%
Race-based hiring • 25%
Yes • 50%
No • 50%
More than 30 complaints • 25%
0-10 complaints • 25%
11-20 complaints • 25%
21-30 complaints • 25%
Other • 25%
Race-based Hiring • 25%
General DEI Programming • 25%
DEI Mental Health Initiatives • 25%
AI and Machine Learning • 25%
Space Exploration • 25%
Biotechnology • 25%
Climate Change Technology • 25%
Human rights and democracy • 25%
Trade and economic policies • 25%
Military and defense • 25%
Other/General diplomacy • 25%
No change • 25%
Decrease • 25%
Increase • 25%
Data not available • 25%
No • 50%
Yes • 50%
Significant positive impact • 25%
Negative impact • 25%
No significant impact • 25%
Moderate positive impact • 25%
Infectious Disease Control • 25%
Other • 25%
Vaccine Development • 25%
Gain-of-Function Research • 25%
Less than 10 • 25%
More than 30 • 25%
21 to 30 • 25%
10 to 20 • 25%